miR-29 family: A potential therapeutic target for cardiovascular disease

被引:37
作者
Liu, Meng-Nan [1 ,2 ,3 ,4 ]
Luo, Gang [3 ,4 ]
Gao, Wan-Jiao [1 ,2 ]
Yang, Si-Jin [1 ,2 ,3 ,4 ]
Zhou, Hua [1 ,2 ]
机构
[1] Macau Univ Sci & Technol, Fac Chinese Med, Taipa, Macao, Peoples R China
[2] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Taipa, Macao, Peoples R China
[3] Southwest Med Univ, Hosp TCM, Natl Tradit Chinese Med Clin Res Base, Luzhou, Sichuan, Peoples R China
[4] Southwest Med Univ, Hosp TCM, Dept Cardiovasc Med, Luzhou, Sichuan, Peoples R China
基金
中国国家自然科学基金;
关键词
MicroRNA; MiR-29; family; Cardiovascular disease; Myocardial fibrosis; Therapeutic target; PULMONARY ARTERIAL-HYPERTENSION; ATRIAL-FIBRILLATION; MICRORNA EXPRESSION; CARDIAC FIBROSIS; HEART-FAILURE; ASSOCIATION; MECHANISMS; PATHOPHYSIOLOGY; CONTRIBUTES; GENOMICS;
D O I
10.1016/j.phrs.2021.105510
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cardiovascular disease (CVD), including heart failure, myocardial fibrosis and myocardial infarction, etc, remains one of the leading causes of mortality worldwide. Evidence shows that miRNA plays an important role in the pathogenesis of CVD. miR-29 family is one of miRNA, and over the past decades, many studies have demonstrated that miR-29 is involved in maintaining the integrity of arteries and in the regulation of atherosclerosis, especially in the process of myocardial fibrosis. Besides, heart failure, myocardial fibrosis and myocardial infarction are inseparable from the regulatory role of miR-29. Here, we comprehensively review recent studies regarding miR-29 and CVD, illustrate the possibility of miR-29 as a potential marker for prevention, treatment and prognostic observation.
引用
收藏
页数:7
相关论文
共 97 条
  • [1] Cardiorespiratory Fitness and Cardiovascular Disease Prevention: an Update
    Al-Mallah, Mouaz H.
    Sakr, Sherif
    Al-Qunaibet, Ada
    [J]. CURRENT ATHEROSCLEROSIS REPORTS, 2018, 20 (01)
  • [2] The potential role of miR-29 in health and cancer diagnosis, prognosis, and therapy
    Alizadeh, Mohsen
    Safarzadeh, Ali
    Beyranvand, Fatemeh
    Ahmadpour, Fatemeh
    Hajiasgharzadeh, Khalil
    Baghbanzadeh, Amir
    Baradaran, Behzad
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (11) : 19280 - 19297
  • [3] Aparina OP, 2014, KARDIOLOGIYA, V54, P57
  • [4] Inflammation and fibrosis in murine models of heart failure
    Bacmeister, Lucas
    Schwarzl, Michael
    Warnke, Svenja
    Stoffers, Bastian
    Blankenberg, Stefan
    Westermann, Dirk
    Lindner, Diana
    [J]. BASIC RESEARCH IN CARDIOLOGY, 2019, 114 (03)
  • [5] ACC/AHA Versus ESC/ESH on Hypertension Guidelines
    Bakris, George
    Ali, Waleed
    Parati, Gianfranco
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (23) : 3018 - 3026
  • [6] MicroRNAs in Cardiovascular Disease
    Barwari, Temo
    Joshi, Abhishek
    Mayr, Manuel
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (23) : 2577 - 2584
  • [7] MicroRNA-29 in Aortic Dilation: Implications for Aneurysm Formation
    Boon, Reinier A.
    Seeger, Timon
    Heydt, Susanne
    Fischer, Ariane
    Hergenreider, Eduard
    Horrevoets, Anton J. G.
    Vinciguerra, Manlio
    Rosenthal, Nadia
    Sciacca, Sergio
    Pilato, Michele
    van Heijningen, Paula
    Essers, Jeroen
    Brandes, Ralf P.
    Zeiher, Andreas M.
    Dimmeler, Stefanie
    [J]. CIRCULATION RESEARCH, 2011, 109 (10) : 1115 - U66
  • [8] What is an RNA? A top layer for RNA classification
    Brosius, Juergen
    Raabe, Carsten A.
    [J]. RNA BIOLOGY, 2016, 13 (02) : 140 - 144
  • [9] The microRNA-29/PGC1α regulatory axis is critical for metabolic control of cardiac function
    Caravia, Xurde M.
    Fanjul, Victor
    Oliver, Eduardo
    Roiz-Valle, David
    Moran-Alvarez, Alba
    Desdin-Mico, Gabriela
    Mittelbrunn, Maria
    Cabo, Roberto
    Vega, Jose A.
    Rodriguez, Francisco
    Fueyo, Antonio
    Gomez, Monica
    Lobo-Gonzalez, Manuel
    Bueno, Hector
    Velasco, Gloria
    Freije, Jose M. P.
    Andres, Vicente
    Ibanez, Borja
    Ugalde, Alejandro P.
    Lopez-Otin, Carlos
    [J]. PLOS BIOLOGY, 2018, 16 (10)
  • [10] Widespread microRNA repression by Myc contributes to tumorigenesis
    Chang, Tsung-Cheng
    Yu, Duonan
    Lee, Yun-Sil
    Wentzel, Erik A.
    Arking, Dan E.
    West, Kristin M.
    Dang, Chi V.
    Thomas-Tikhonenko, Andrei
    Mendell, Joshua T.
    [J]. NATURE GENETICS, 2008, 40 (01) : 43 - 50